Advertisement

Coincidence of lymphomatoid granulomatosis, chronic myelomonocytic leukemia, and anaplastic T cell lymphoma after methotrexate therapy for rheumatoid arthritis

  • Rucha Dugge
  • Hans Kreipe
  • Andreas Rosenwald
  • Ulrich Lehmann
  • Peter Möller
  • Thomas F. E. Barth
  • Rainer Erlemann
Letter to the Editor
  • 34 Downloads

Notes

Acknowledgements

The authors would like to thank the Interdisciplinary Bank of Biomaterials and Data of the University Hospital of Würzburg and the Julius Maximilian University of Würzburg (idbw). The implementation of the ibdw has been supported by a Bundesministerium für Bildung und Forschung (Grant number FKZ: 01EY1102). Rucha Dugge is a student of the Research Training Group 2254: Heterogeneity and Evolution in Solid Tumours (HEIST) at Ulm University funded by the Deutsche Forschungsgemeinschaft.

Authorship Contributions

T.F.E.B., H.K., A.R., U.L., P.M., and R.E. designed the research and analyzed and interpreted data. T.F.E.B. and R.D. wrote the manuscript.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. All the performed methods and experiments were in line with the guidelines of the ethics committee of the Federal General Medical Council. Informed consent was obtained from the individual included in the study.

References

  1. 1.
    Oiwa H, Mihara K, Kan T, Tanaka M, Shindo H, Kumagai K, Sugiyama E (2014) Grade 3 lymphomatoid granulomatosis in a patient receiving methotrexate therapy for rheumatoid arthritis. Intern Med 53(16):1873–1875CrossRefPubMedGoogle Scholar
  2. 2.
    Yoshida Y, Takahashi Y, Yamashita H, Kano T, Kaneko H, Mimori A (2014) Clinical characteristics and incidence of methotrexate-related lymphoproliferative disorders of patients with rheumatoid arthritis. Mod Rheumatol 24(5):763–765CrossRefPubMedGoogle Scholar
  3. 3.
    Fialkow PJ, Jacobson RJ, Papayannopoulou T (1977) Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. Am J Med 63(1):125–130CrossRefPubMedGoogle Scholar
  4. 4.
    Tefferi A, Pardanani A, Lim KH, Abdel-Wahab O, Lasho TL, Patel J, Gangat N, Finke CM, Schwager S, Mullally A, Li CY, Hanson CA, Mesa R, Bernard O, Delhommeau F, Vainchenker W, Gilliland DG, Levine RL (2009) TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis. Leukemia 23(5):905–911CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Yoshida K, Sanada M, Shiraishi Y, Nowak D, Nagata Y, Yamamoto R, Sato Y, Sato-Otsubo A, Kon A, Nagasaki M, Chalkidis G, Suzuki Y, Shiosaka M, Kawahata R, Yamaguchi T, Otsu M, Obara N, Sakata-Yanagimoto M, Ishiyama K, Mori H, Nolte F, Hofmann WK, Miyawaki S, Sugano S, Haferlach C, Koeffler HP, Shih LY, Haferlach T, Chiba S, Nakauchi H, Miyano S, Ogawa S (2011) Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 478(7367):64–69CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Rucha Dugge
    • 1
  • Hans Kreipe
    • 2
  • Andreas Rosenwald
    • 3
  • Ulrich Lehmann
    • 2
  • Peter Möller
    • 1
  • Thomas F. E. Barth
    • 1
  • Rainer Erlemann
    • 4
  1. 1.Institute of PathologyUlm UniversityUlmGermany
  2. 2.Institute of PathologyMedizinische Hochschule HannoverHannoverGermany
  3. 3.Institute of PathologyJulius Maximilian University of Würzburg and Comprehensive Cancer Center MainfrankenWürzburgGermany
  4. 4.Institute of RadiologyDuisburgGermany

Personalised recommendations